These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1354058)

  • 1. Measurements of plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kahn RS; Stern RG; Harvey PD; Keefe R; Knott P; Apter S; Webster L; Davis KL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():521A-522A. PubMed ID: 1354058
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma homovanillic acid and prognosis in schizophrenia.
    Baker NJ; Kirch DG; Waldo M; Bell J; Adler LE; Hattox S; Murphy R; Freedman R
    Biol Psychiatry; 1991 Jan; 29(2):192-6. PubMed ID: 1671646
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma HVA, neuroleptics, and dopaminergic plasticity.
    Dávila R
    Biol Psychiatry; 1989 Jan; 25(1):1-3. PubMed ID: 2563229
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 6. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M
    Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E; Bollini AM; Sanfilipo M; Wieland S; Angrist B; Cooper TB; Rotrosen J
    Schizophr Res; 2006 Jan; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract]   [Full Text] [Related]  

  • 9. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
    Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H; Suzuki E; Kanba S; Nibuya M; Ishizuki T; Kohno H; Kinoshita N; Shintani F; Yagi G; Nakaki T
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):79-81. PubMed ID: 1679276
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of plasma HVA and treatment response in a large series of patients with schizophrenia.
    Davila R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():519A-520A. PubMed ID: 1354057
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis.
    Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.
    Zumárraga M; González-Torres MA; Arrue A; Dávila R; Dávila W; Inchausti L; Pérez-Cabeza L; Fernández-Rivas A; Bustamante S; Basterreche N; Guimón J
    Neurochem Res; 2011 Aug; 36(8):1336-43. PubMed ID: 21475956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
    Miura I; Kanno-Nozaki K; Hino M; Horikoshi S; Ota T; Mashiko H; Niwa S; Yabe H
    J Clin Psychopharmacol; 2015 Jun; 35(3):333-4. PubMed ID: 25871573
    [No Abstract]   [Full Text] [Related]  

  • 15. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL
    Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
    Pickar D; Labarca R; Linnoila M; Roy A; Hommer D; Everett D; Paul SM
    Science; 1984 Aug; 225(4665):954-7. PubMed ID: 6474162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia: gender, family risk, and plasma homovanillic acid.
    Dávila R; Zumárraga M; González-Torres MA; Andía I; Zamalloa MI; Basterreche E; Guimón J; Friedhoff AJ
    Am J Med Genet; 1995 Apr; 60(2):154-6. PubMed ID: 7485251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Powchick P; Freed LB; Kaminsky R; Davis KL
    Psychopharmacol Bull; 1987; 23(3):407-10. PubMed ID: 3432512
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
    Kelley ME; Yao JK; van Kammen DP
    Neuropsychopharmacology; 1999 Jun; 20(6):603-11. PubMed ID: 10327429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z; Davidson M; Jaff S; McQueeney R
    Schizophr Res; 1991; 5(1):81-3. PubMed ID: 1677266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.